Table 1 Characteristics of included funding applications
Outline application (Stage 1) (n = 95) | Full application (Stage 2) (n = 49) | |
|---|---|---|
Therapeutic areasa | ||
Oncology | 12 (13%) | 5 (10%) |
Psychiatry/Ppychology | 12 (13%) | 7 (14%) |
Paediatrics | 10 (11%) | 7 (14%) |
Respiratory | 7 (7%) | 4 (8%) |
Primary care | 7 (7%) | 1 (2%) |
Gastroenterology/hepatology | 6 (6%) | 3 (6%) |
Trauma | 5 (5%) | 4 (8%) |
Other | 36 (38%) | 18 (37%) |
Intervention type | ||
Drug | 9 (9%) | 4 (8%) |
Surgery or procedure | 15 (16%) | 8 (16%) |
Counselling, lifestyle or physiotherapy | 55 (58%) | 28 (57%) |
Equipment | 4 (4%) | 3 (6%) |
Medical device | 1 (1%) | 1 (2%) |
Other | 11 (12%) | 5 (10%) |
Randomisation design | ||
Parallel | 84 (88%) | 45 (92%) |
Parallel + patient preference arms | 2 (2%) | 0 (0%) |
Cluster | 9 (9%) | 4 (8%) |
Sample size | ||
Sample size unclear in funding application | 4 | 0 |
Min-max | 20-250 | 25-800 |
Median | 60 | 60 |
IQR | 50-90 | 50-80 |
Single/multi-centre | ||
Single | 19 (20%) | 10 (20%) |
Multi | 69 (73%) | 36 (73%) |
Unclear | 7 (7%) | 3 (6%) |
Number of arms | ||
2 | 84 (88%) | 44 (90%) |
>2 | 11 (12%) | 5 (10%) |
Primary focus is the assessment of feasibility | ||
Yes | 94 (99%) | 49 (100%) |
Nob | 1 (1%) | 0 (0%) |
Qualitative research conducted | ||
Yes | 80 (84%) | 44 (90%) |
No | 15 (16%) | 5 (10%) |